Ring 1
Ring 2
Ring 3
Ring 4


Financing Rounds

  • Series A
  • Series B
Round Led by Symbiosis
Round Led by Symbiosis

Ensoma believes the future of medicine lies within us. Its Engenious™ gene therapy platform is the first to precisely engineer any or all hematopoietic and immune cells with a one-time, off-the-shelf in vivo treatment. Engenious therapies have an unmatched capacity to deliver all modern genetic modification tools and set a new standard for versatile cell programming and control across a range of complex diseases.

ensoma View Website


  • Genetic Medicine


  • Other

Development Status

  • Pre-Clinical